Financhill
Back

Target Vs. Cytokinetics Industry Stock Comparison

Sell
43

TGT
Target

Last Price:
141.15
Seasonality Move:
1.39%
Buy
55

CYTK
Cytokinetics

Last Price:
53.96
Seasonality Move:
7.55%
Sell
43
Target (TGT) is a Sell

Is Target a Buy, Sell or Hold?

  • The current Target [TGT] share price is $141.16. The Score for TGT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • TGT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
55
Cytokinetics (CYTK) is a Buy

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $53.93. The Score for CYTK is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
  • CYTK is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TGT Stock Price Chart

What is Target's stock price today?

  • The Target share price today is $141.16
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TGT is experiencing slight selling pressure.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $53.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing buying pressure, which is a positive indicator for future bullish movement.

TGT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.82 Sell
Relative Strength Index (14 RSI): 33.97 Sell
Chaikin Money Flow: -964475 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (144.65 - 157.51) Sell
Bollinger Bands (100): (146.79 - 168.51) Sell

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.04 Sell
Relative Strength Index (14 RSI): 46.58 Sell
Chaikin Money Flow: 781761 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.51 - 58.99) Sell
Bollinger Bands (100): (57.71 - 76.51) Sell

TGT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 145.73 Sell
20-day SMA: 148.79 Sell
50-day SMA: 157.9 Sell
200-day SMA: 141 Buy
8-day EMA: 145.75 Sell
20-day EMA: 149.28 Sell
50-day EMA: 154.35 Sell
200-day EMA: 149.36 Sell

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 53.47 Buy
20-day SMA: 52.83 Buy
50-day SMA: 60.85 Sell
200-day SMA: 55.3 Sell
8-day EMA: 53.07 Buy
20-day EMA: 54.08 Sell
50-day EMA: 58.8 Sell
200-day EMA: 57.11 Sell

Target Earnings Growth & TGT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.80 per share, an increase next quarter of $0.20 per share, an increase this year of $2.81 per share, and an increase next year of $1.01 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.31 per share, an increase next quarter of $0.01 per share, an increase this year of $0.60 per share, and an increase next year of $0.05 per share.

Target Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):